ANGIOGENESIS is a prestigious academic journal published by Springer, focusing on the vital field of angiogenesis research, a cornerstone in understanding tumor biology and tissue regeneration. Established in 1997 and continuously evolving, this journal has solidified its reputation, ranking in the Q1 category for Cancer Research, Clinical Biochemistry, and Physiology as of 2023. With an impressive impact factor, it serves as an essential platform for disseminating cutting-edge research findings, critical reviews, and novel methodologies. ANGIOGENESIS is indexed in high-impact databases and exhibits exceptional Scopus ranks—1st in Clinical Biochemistry, 6th in Physiology, and 14th in Cancer Research, underscoring its significant contribution to the scientific community. Although it does not currently offer open access options, it ensures that all articles maintain rigorous peer-review standards to meet the highest academic excellence. Researchers, professionals, and students alike will find ANGIOGENESIS to be an invaluable resource in advancing their knowledge and research in the intricate mechanisms of vascular biology.

Artery Research is an esteemed open access journal published by BMC in the United Kingdom, dedicated to advancing the field of vascular biology and cardiovascular medicine. Since its inception in 2006 and transitioning to an open access format in 2019, the journal has become a pivotal platform for disseminating high-quality research on arterial health, pathology, and the latest clinical advancements. With an impactful focus on anatomy, cardiology, and physiology, Artery Research holds a notable reputation within the global research community, ranked in the Q3 and Q4 category quartiles in its respective fields and reflected in its Scopus ranks. The journal aims to foster collaborations and discussions among researchers and practitioners by providing an accessible avenue for publishing pivotal findings and insights. As it continues to evolve through 2024 and beyond, Artery Research remains committed to enriching cardiovascular research and driving innovations toward better health outcomes.

JOURNAL OF CARDIOVASCULAR SURGERY, published by EDIZIONI MINERVA MEDICA, stands as a pivotal resource in the field of cardiovascular medicine and surgical practices. With a rich history dating back to 1960 and ongoing contributions scheduled until 2024, this esteemed journal provides a platform for the dissemination of innovative research in cardiology and surgical techniques. Registered under ISSN 0021-9509 and E-ISSN 1827-191X, it holds a commendable standing reflected in its Scopus rankings, placing it in the second quartile for both cardiology and cardiovascular medicine, as well as surgery. Despite not currently offering Open Access, the journal remains a vital source for practitioners and researchers alike, facilitating a deeper understanding of advancing methodologies and clinical practices in cardiovascular surgery. The journal is headquartered in Turin, Italy, and is committed to nurturing academic excellence within the community, making it an essential read for professionals, researchers, and students striving to enhance their knowledge and expertise in this critical field.

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

The Indian Journal of Vascular and Endovascular Surgery, published by Wolters Kluwer Medknow Publications, serves as a premier platform dedicated to advancing research and clinical practices in the fields of vascular and endovascular surgery. With an E-ISSN of 2394-0999 and a commitment to open access since 2015, this journal provides invaluable insights to researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of knowledge. By focusing on innovative techniques, case studies, and systematic reviews, the journal plays a vital role in enhancing clinical outcomes and promoting evidence-based practices within the vascular community. Its commitment to high-quality research and accessibility positions it as an essential resource in the landscape of surgical literature, encouraging further exploration and collaboration within this critical area of healthcare.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, published by the American Physiological Society, is a premier journal dedicated to advancing the understanding of cardiovascular physiology. With an ISSN of 0363-6135 and an E-ISSN of 1522-1539, this esteemed journal has been a vital resource since its inception in 1977, and continues to publish cutting-edge research that shapes the fields of cardiology and physiology. Recognized as a Q1 journal in multiple categories, it ranks impressively within the top tier of its fields, including a notable 18th percentile rank in Physiology (medical). The journal’s impact factor and extensive reach in the academic community affirm its significance in promoting innovative studies and insights. While it does not offer open access options, the journal remains accessible through institutional subscriptions, making it an essential tool for researchers, professionals, and students alike, who are keen to stay abreast of the latest developments in heart and circulatory physiology. For further information, the journal is based in the United States at 6120 Executive Blvd, Suite 600, Rockville, MD 20852. As a cornerstone of cardiovascular research, it invites contributions that push the boundaries of knowledge and enhance clinical practice.

CIRCULATION RESEARCH is a premier journal dedicated to advancing the field of cardiovascular science, focusing on innovative research in cardiology and physiology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of cardiovascular research since its inception in 1953, maintaining rigorous standards of scholarly excellence. With an impressive impact factor and ranking in the top quartiles for both Cardiology and Cardiovascular Medicine (Q1) and Physiology (Q1), it holds a significant position in the Scopus database. This journal features cutting-edge studies aimed at understanding the mechanisms of cardiovascular health and disease, promoting the translation of research into clinical practice. Weekly issues provide practitioners and researchers alike with vital insights to keep abreast of the latest developments. Although it does not offer open access, CIRCULATION RESEARCH remains vital for professionals striving to enhance their knowledge and impact in the ever-evolving landscape of cardiovascular medicine.

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

Annals of Vascular Diseases is a leading international journal dedicated to the comprehensive exploration of vascular pathology, aimed at advancing knowledge in the field through innovative research and insightful reviews. Published by the ANNALS VASCULAR DISEASES EDITORIAL OFFICE and available in both print (ISSN: 1881-641X) and electronic format (E-ISSN: 1881-6428), this journal has embraced Open Access since 2017, facilitating wider dissemination and accessibility of vital research findings. With its focus on clinical and experimental studies relating to vascular diseases, the journal serves as a crucial platform for researchers, medical professionals, and students who seek to stay at the forefront of clinical advancements. By fostering collaboration and sharing knowledge, Annals of Vascular Diseases plays a significant role in shaping the future of vascular research and treatment strategies worldwide.

Vascular Pharmacology, published by Elsevier Science Inc, is a leading journal in the fields of pharmacology and molecular medicine, dedicated to advancing our understanding of vascular biology and therapeutic interventions. With an impressive impact factor reflecting its significant contribution to the scientific community, this journal seeks to publish ground-breaking research that elucidates the molecular mechanisms underlying vascular function and disease, as well as the pharmacological impact of new therapeutic agents. The journal operates under a dual access model, allowing for both subscription and open access options, ensuring that vital research is accessible to a wide audience. As of 2023, it holds a prestigious position in the Q1 category for pharmacology and ranks well in molecular medicine and physiology, reflecting its high quality and relevance. Whether you are a researcher, clinician, or student, Vascular Pharmacology serves as an essential resource to stay at the forefront of cardiovascular pharmacotherapy and vascular biology.